Important pharmacy news and late-breaking industry information updated daily.
Transthyretin amyloid cardiomyopathy is a life-threatening disease characterized by the accumulation of amyloid fibrils composed of misfolded transthyretin protein in the heart. Symptoms for the disease are predominately manifested in male patients aged 60 years or older.
Aspirin has been shown to lower the risk of a second heart attack or stroke. But a randomized trial with more than 12,500 people — considered to be at moderate risk for cardiovascular disease — found the rate of heart problems did not differ between people taking aspirin and those on placebo.
This report updates the 2017–18 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States. Routine annual influenza vaccination is recommended for all persons aged 6 months or older who do not have contraindications.
Pharmacists can have patients practice proper EAI use in the pharmacy
A combination of two drugs — ipilimumab (Yervoy—Bristol-Myers Squibb) and nivolumab (Opdivo—Bristol-Myers Squibb) — that activate the immune system shrank brain tumors in many melanoma patients and prolonged life in a study of 94 people at 28 medical centers in the United States.
FDA on Tuesday took additional action to mitigate shortages of EpiPen (epinephrine) auto-injector by extending the expiration date of specific lots of 0.3 milligram products marketed by Mylan by 4 months beyond the labeled expiration date.
This would mark the third straight year of reductions
Scientists funded by the National Eye Institute (NEI) report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease.
Recall includes porcine thyroid ingredients, Westminster Pharmaceutical products
HHS Secretary Alex Azar says it is within his agency's power to eliminate rebates on prescription drug purchases, asserting they create a perverse incentive to continuously raise drug prices. HHS last month proposed regulations that would scale back protections for rebates that might otherwise be illegal under a federal anti-kickback law.